Home / Knowledge Centre /
Article

Nuclear Magnetic Resonance: The new gold standard release test of the future?

In this article, Anna Cousens, Global Analytical Business Development Manager at Almac Sciences, explores how quantitative NMR (QNMR) is now being used as an attractive alternative to traditional HPLC for the determination of structural data of both pharmaceutical active ingredients and impurities.

Read full article here

Almac Logo

Almac API, Chemical Development, Analytical & Solid State Services

Almac Sciences provides integrated services from development to commercial scale of advanced intermediates and Active Pharmaceutical Ingredients (API).

We provide a range of services for small molecules (including highly potent) and peptides. We have a proven track record of saving time and cost through the integration of our services and application of innovative biocatalysis and technology solutions.

Learn More

We offer a full suite of analytical testing for a range of different product types including small molecules, peptides, biologics, conjugates, potent and controlled substances.

Our vast pool of scientific knowledge can help to overcome the analytical challenges that typically arise during drug development.

Learn More

Please complete this form to view the Article

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies